LUNG
Price:
$1.28
Market Cap:
$54.06M
Pulmonx Corporation is a biomedical technology firm dedicated to developing and commercializing advanced, less invasive devices for managing chronic obstructive pulmonary diseases. Its primary offering, the Zephyr Endobronchial Valve, is specifically engineered to treat bronchoscopic hyperinflation in adults afflicted with severe emphysema. Complementing its therapeutic solutions, the company also provides the Chartis Pulmonary Assessment System. This system features a specialized balloon catheter and console, fitted with flow and pressure sensors, which is instrumental in evaluating the presence of collateral ventilation in patients. Additionally, Pulmonx offers the StratX Lung Analysis Pla...[Read more]
Industry
Medical - Devices
IPO Date
2020-10-01
Stock Exchange
NASDAQ
Ticker
LUNG
According to Pulmonx Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 48.78M. This represents a change of -24.49% compared to the average of 64.61M of the last 4 quarters.
The mean historical Enterprise Value of Pulmonx Corporation over the last ten years is 843.63M. The current 48.78M Enterprise Value has changed 478.27% with respect to the historical average. Over the past ten years (40 quarters), LUNG's Enterprise Value was at its highest in in the December 2020 quarter at 2.14B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.
Average
843.63M
Median
642.80M
Minimum
76.27M
Maximum
2.26B
Discovering the peaks and valleys of Pulmonx Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 90.26%
Maximum Annual Enterprise Value = 2.26B
Minimum Annual Increase = -77.29%
Minimum Annual Enterprise Value = 76.27M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 76.27M | -69.63% |
| 2024 | 251.13M | -43.19% |
| 2023 | 442.05M | 87.80% |
| 2022 | 235.39M | -77.29% |
| 2021 | 1.04B | -54.11% |
| 2020 | 2.26B | 40.75% |
| 2019 | 1.60B | 90.26% |
The current Enterprise Value of Pulmonx Corporation (LUNG) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
256.48M
5-year avg
408.30M
10-year avg
843.63M
Pulmonx Corporation’s Enterprise Value is less than Edap Tms S.a. (193.07M), less than Vaxart, Inc. (90.35M), less than Relmada Therapeutics, Inc. (483.76M), greater than Acrivon Therapeutics, Inc. Common Stock (17.89M), greater than PMV Pharmaceuticals, Inc. (21.43M), greater than Immunic, Inc. (-46074746.00), less than Hyperfine, Inc. (107.32M), less than Assertio Holdings, Inc. (158.46M), greater than TScan Therapeutics, Inc. (20.67M), less than TELA Bio, Inc. (52.71M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 193.07M | $178.23M | |
| 90.35M | $133.12M | |
| 483.76M | $493.54M | |
| 17.89M | $49.54M | |
| 21.43M | $60.26M | |
| -46074746.00 | $140.13M | |
| 107.32M | $134.74M | |
| 158.46M | $151.86M | |
| 20.67M | $56.19M | |
| 52.71M | $35.86M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pulmonx Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pulmonx Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Pulmonx Corporation's Enterprise Value?
What is the highest Enterprise Value for Pulmonx Corporation (LUNG)?
What is the 3-year average Enterprise Value for Pulmonx Corporation (LUNG)?
What is the 5-year average Enterprise Value for Pulmonx Corporation (LUNG)?
How does the current Enterprise Value for Pulmonx Corporation (LUNG) compare to its historical average?